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Summary
Sphingolipids of yeast have been described as being
important for numerous cell biological phenomena
such as heat resistance, endocytosis, stress resis-
tance and many others. The genetic or pharmacologi-
cal elimination of speciﬁc features or entire classes of
sphingolipids has pinpointed speciﬁc sphingolipids
as pivotal regulators in many processes. The report
by Epstein et al. adds two new tools for such studies:
a strain being completely resistant to aureobasidin A,
a speciﬁc inhibitor of inositol phosphorylceramide
synthase and a second strain where this synthase is
deleted. The resulting phenotypes advocate new
roles of complex sphingolipids in cytokinesis, lipid
droplet biogenesis and cell survival.
Introduction
Most genes for sphingolipid biosynthesis and degradation
in yeast have been identiﬁed (Fig. 1) and there now is a
wealth of data demonstrating that sphingolipids are
required for numerous essential and non-essential cell
biological phenomena such as resistance to heat, high salt,
low pH, endocytosis, vacuolar acidiﬁcation, cell wall integ-
rity, chronological aging, transport of GPI proteins and
nutrient transporters from theER to the plasmamembrane,
functionality of plasma membrane nutrient transporters,
and many others (for review see Dickson, 2010). In only
very few cases, however, a given sphingolipid has been
shown to bind directly to a particular target protein in the
same way as for instance C18-sphingomyelin has recently
been shown to bind to the transmembrane domain of
mammalian p24 (Contreras et al., 2012). In a majority of
studies, speciﬁc sphingolipids have been proposed to be
required for a speciﬁc processmainly through the compari-
son of phenotypic consequences of successive gene dele-
tions along the biosynthetic pathway. For example, if a
given process X is not affected by deletion of IPT1 but by
deletion of CSG2 (Fig. 1), one may conclude that the
process depends on mannosyl-inositol phosphorylceram-
ide (MIPC). Yet, it also needs to be considered that the
process X may be perturbed by accumulation of inositol
phosphorylceramide (IPC), a possibility that can be
excluded if process X is also blocked by aureobasidin A
(AbA), a highly speciﬁc pharmacological inhibitor of IPC
synthase Aur1p. Indeed, several other mutations have
been reported where the accumulation of upstream rather
than the lack of downstream metabolites seems to be
responsible for a compromised process X (Saba et al.,
1997; Beeler et al., 1998; Schorling et al., 2001; Aguilar
et al., 2010). Thus, downregulation of many successive
enzymatic steps is required to pinpoint the speciﬁc lipids
required for a speciﬁc cellular function.
Two new tools
In this issue, two new tools for yeast sphingolipid research
are introduced by the paper by Epstein et al. The report
introduces a cell line, which is completely AbA resistant
even though it makes high amounts of ceramides. It fur-
thermore relates the successful deletion of AUR1 in this
strain, thereby for the ﬁrst time creating yeast cells that lack
all complex sphingolipids (Fig. 1). Aur1p transfers inositol-
phosphate from phosphatidylinositol (PI) onto ceramides
to form IPCat the luminal side ofGolgimembranes (Nagiec
et al., 1997; Levine et al., 2000). Similar to ergosterol
biosynthesis, the early steps of yeast sphingolipid biosyn-
thesis are covered by essential genes or redundant gene
pairs, simultaneous deletion of which is lethal (red and
green, respectively, in Fig. 1). A second site suppressor
mutation can rescue lcb1D cells, and the lag1D lac1D
double deletion is not lethal in all genetic backgrounds, but
no suppressors were found so far for deletions abolishing
fatty acid elongation or IPC synthesis. Also, AbA has been
reported to rapidly kill cells (Endo et al., 1997). Similarly,
the biosynthesis of sphingomyelin, the mammalian coun-
terpart of IPCs, is essential for proliferation of mammalian
cells (Tafesse et al., 2007). A ﬁrst hint that lethality of the
AUR1 deletion may be rescued came from the observation
that a lag1D lac1D ypc1D ydc1D (4D) mutant, largely unable
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to make ceramides, is resistant to AbA (Schorling et al.,
2001). This observation suggested that aur1D LAG1 cells
may die not for lack of complex sphingolipids, but rather
because ceramides reach toxic levels in such cells. The
ﬁnding of Schorling et al. could not be reproduced by
others when very high concentrations of AbA (2.5 mg ml-1)
were used to grow the 4D mutant (Cerantola et al., 2009).
Building on past experience, Epstein et al. (2012) tried to
generate the AUR1 deletion in lag1D lac1D cells harbour-
ing GhLAG1, a LAG1 homologue from cotton (Gossypium
hirsutum) inserted into the TRP1 locus. The resulting
GhLag1 strain (TDH3::GhLAG1::TRP1 lac1D lag1D)
differs from normal yeast in two ways: it makes ceramides
and complex sphingolipids with C18 fatty acids rather than
C26 fatty acids (Fig. 1) and it contains signiﬁcantly (three-
fold) higher amounts of ceramide and also of complex
sphingolipids than wild type (WT). This cell line turns out to
be completely resistant toAbAalthough its ceramide levels
under AbA still increase by a factor of 3.5, an increase that
is comparable to the one observed for WT cells, whereby
WT cells stop growing and die on AbA, whereas GhLag1
continue to grow. The conclusion seems evident: accumu-
lation of C26-ceramides is toxic, accumulation of C18-
ceramides is not. A recent study demonstrates that elo3D,
making C22 and a little C24 but no C26 fatty acids (Fig. 1),
are quite AbA-resistant, suggesting also that C22 ceram-
ides are less toxic than C26 ceramides (Tani and Kuge,
2010).
The AbA hyper-resistant phenotype of GhLag1 cells
encouraged Epstein et al. (2012) to try to generate a
TDH3::GhLAG1::TRP1 lac1D lag1D aur1D. Such a strain,
called cSLD because lacking all complex sphingolipids,
was obtained by sporulating a diploid which is heterozy-
gous at all four loci. This avoids the selection for suppres-
sor mutations and the results very clearly indicate that
AUR1 deletion in GhLag1 is possible.1
Anything wrong with GhLag1?
Apart from beingAbA resistant, GhLAG1 cells cannot grow
in presence of Calcoﬂuor white, YW3548 (an inhibitor of
GPI precursor biosynthesis) and rapamycin, indicating
someproblem inmaking and remodelling the cell wall. That
sphingolipids inﬂuence the cell wall architecture had been
realized for a long time and by many authors: e.g. lag1D
lac1D mutants have abnormal, multilayered cell walls and
are Calcoﬂuor white hypersensitive (Barz and Walter,
1999). Similarly, growth inhibition by myriocin can be over-
come by overexpression of MSS4, ROM2, RHO1 and
further downstream elements required for activation of the
cell wall integrity pathway (Kobayashi et al., 2005). Part of
this rescue may be due to a stimulatory effect of Rom2p on
ceramide synthesis indicated by genetic data (Aguilar
et al., 2010). One explanation for cell wall abnormalities in
sphingolipid-deﬁcient mutants is that numerous cell wall
proteins are GPI proteins whose export out of the ER is
dependent on ceramide-biosynthesis (Barz and Walter,
1999). However, data of Epstein et al. (2012) suggest that
the abundant C18-ceramides and complex C18-
sphingolipids of GhLag1 are functional for GPI protein
transport since, Gas1p, Cwp2p, Pma1p and many other
membrane proteins are not accumulating inside GhLag1
cells but are found at the plasmamembrane as inWT cells.
Asimilar conclusion was reached in an earlier report where
pulse chase studies showed a normal ER toGolgi transport
of Gas1p in a 4D strain harbouring a murine CERS5, a
LAG1 homologue that also makes C16 and C18 ceram-
ides. This strain also was Calcoﬂuor white hypersensitive
(Cerantola et al., 2007). Therefore, the reason for the cell
wall problem of GhLag1 cells is presently unexplained.
What about phenotypes of cSLD?
In spite of the robust growth of GhLag1 on 0.5 mg ml-1 of
AbA, removing their AUR1 leaves the resulting cSLD cells
very sick. This is not so surprising since long-term AbA
treatment of GhLag1p represses IPC levels without
causing a proportional decrease in M(IP)2C (Epstein
1The lower-than-expected frequency of quadruple mutants (3 instead
of the expected 12) is most likely due to the fact that two loci
(AUR1 = YKL004w and LAC1 = YKL008c) are linked.
Fig. 1. Major pathways of sphingolipid biosynthesis in yeast.
Gene names are in italic and inhibitors in bold italics. DHS,
dihydrosphingosine; IPC, inositol phosphorylceramide; LCB, long
chain base; MIPC, mannosyl-IPC; P, phosphate; PHS,
phytosphingosine; M(IP)2C, inositolphosphoryl-MIPC. Essential
genes in red, redundant gene pairs, simultaneous deletion of which











et al., 2012 herein ﬁg. 2E). It is possible that the partial
inhibition of Aur1p creates a situation where the down
stream processing steps are no more rate limiting and can
handle the entire pool of IPC that still is generated.
Epstein et al. (2012) propose that the fragility and slow
growth phenotype of cSLCD cells can be explained by two
discrete difficulties in cytokinesis. While nuclear division
takes place normally, cSLD cells seem to retain the septin
protein Cdc10p at the bud neck longer than normal and
second, they remain attached to each other while some
kind of septum already has created a tight barrier for
cytosolic proteins. Importantly, cSLD cells can be grown in
liquid culture only when shaking is omitted. This latter
phenotype and the ruffled appearance of cSLCD cell walls
in scanning electron microscopy suggest that the problem
in cell separation and cell wall remodelling is much more
severe than in lac1D lag1D cells alluded to above (Barz
and Walter, 1999). This is not astonishing since lac1D
lag1D cells still make small amounts of complex sphin-
golipids through alternative pathways (Vionnet et al.,
2011). The defect of cSLD cells is somewhat reminiscent
of the cell separation defect of gpi7 cells making GPI
anchors of slightly abnormal structure, a defect that
results in the failure to localize the GPI anchored Egt2p
b-glucanase at the bud neck of the daughter cell during
abscission (Fujita et al., 2004). Again, the growth defect of
gpi7 is much less severe than the one of cSLD. A detailed
analysis of the events at the bud neck in cSLD cells may
therefore bring to light a novel role of some complex
sphingolipid in late cytokinesis. More detailed analysis of
cSLD cells will also be required to explain the high mor-
tality rate of their daughter cells and their tendency to
accumulate lipid droplets.
The cSLD may be deﬁcient in previously reported roles of
complex sphingolipids
An early series of studies showed that a lcb1D mutant can
live without importing long chain bases (LCBs) from the
medium if it can make PI with a C26 fatty acid in the sn-2
position of the L-glycerol moiety due the SLC1-1 gain of
function mutation (Nagiec et al., 1993), whereby the lcb1D
SLC1-1 cells are unable to tolerate heat, high salt and low
pH. The SLC1-1 mutation also rescues growth of certain
4D cells on AbA, although it is not known if its cell wall
abnormality is alleviated (Vionnet et al., 2011). The
C26-PI stereochemically resembles the normal IPCs,
which also carry a C26 fatty acid on the C2-linked amino
group of the LCB and recent data show that C26-PI needs
to be mannosylated by Csg1p in order to suppress the
growth inhibition imposed by myriocin (Vionnet et al.,
2011). This points to the importance of MIPC in such
sphingolipid depleted strains. Similarly, MIPC was also
shown to be involved in recruiting the essential PI4P
5-kinase Mss4p to the plasma membrane and thereby
activate Rom2p, a GEF of Rho1p and Rho2p, thus allow-
ing for the activation of the cell wall integrity pathway, a
process that enables cells to grow in the presence of
myriocin (Kobayashi et al., 2005). Interestingly, recruit-
ment of septins, in particular of Cdc10p to the bud neck
and ordering them into ﬁlaments, may be dependent on
PI4,5bisP also in yeast, in analogy to S. pombe, fruit ﬂies
and man, where PI4,5bisP has actually been shown to
accumulate at the cleavage furrow (Bertin et al., 2010).
However, it is not clear at present if the concentration of
PI4,5bisP at the yeast bud neck is dependent on MIPC-
mediated Mss4p recruitment. Also, csg1D and csg2D
(Fig. 1) were not picked up in screens testing the library of
non-essential gene deletions for cell wall defects, sug-
gesting that the Mss4p-recruitment by MIPC is absolutely
required only in cells lacking the early sphingolipid bio-
synthetic intermediates.
Some membrane property is altered within 10 min of
AbA treatment of yeast cells and triggers a regulatory feed
back mechanisms that results in the activation of Lcb1p/
Lcb2p. The signal is transmitted through a TORC2-Slm1/
2p-Ypk1p-Orm1/2p cascade (Roelants et al., 2011;
Berchtold et al., 2012). As mechanical stress of the mem-
brane also activates the Ypk1p-mediated Orm1/2p activa-
tion, it may be that it is a change in physical properties of
the membrane rather than the absence of a speciﬁc sph-
ingolipid that is sensed in this feedback loop. A good case
has been made for MIPC to act as an activator of protein
kinases Fpk1/2p, (Roelants et al., 2010). MIPC-activated
Fpk1/2p and Ypk1p mutually phosphorylate and thereby
inactivate each other, possibly allowing MIPC to down-
regulate the activation of Lcb1/2p that is caused by lack of
complex sphingolipids (see above). In summary, some
roles of MIPC may partly explain the cytokinesis defect of
cSLD cells. The severity of this defect in cSLD, however,
seems to suggest that complex sphingolipids may yet play
a further, not-yet-known role in cell separation.
Outlook
The study of cSLD, crippled as it is, may reveal new
processes depending on complex sphingolipids. Similarly,
use of GhLag1 will allow investigation in more detail of
some cell biological processes that have been recognized
to be dependent on complex sphingolipids and to ask
speciﬁcally whether sphingolipids with very long chain
fatty acids are required. GhLag1 also for the ﬁrst time
allow to acutely reduce IPC levels using AbA, remaining
conﬁdent that the observed phenotypes are not the con-
sequence of acute ceramide intoxication and imminent
cell death. It is to be expected that many sphingolipid
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